Delivery Order SPE2DB22D2007-SPE2DB25FH8AG

Award Date 12/27/24
Potential Completion Date 12/30/24
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,862.39 firm fixed-price delivery order is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $12,470.99 with a Firm Fixed Price pricing type. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of ACTEMRA 200 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,362.04 delivery order is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,010.54, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty injectable medication, to support military and government healthcare programs. The award is a delivery order placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $6,577.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular order is for ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML,...
This federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical is a $11,434.26 delivery order for 4,566,066,941 units of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not utilize a set-aside designation. This order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award, valued at $25,595.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ACTEMRA 400 MG/20 ML VIAL 20ML, a prescription medication, with a completion date of May 29, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.39 firm-fixed-price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes, with a completion date of October 25, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,571.72 firm fixed price delivery order contract, awarded on October 16, 2024, is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8AG
    Delivery Order

This federal contract award, valued at $43,173.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific product being procured under this award is ACTEMRA 400 MG/20 ML VIAL 20ML. The contract does not have a set-aside designation, indicating open competition.

Generated 4/1/25, 3:44 PM